OSCR Intrinsic Value

Intrinsic Value of OSCR Overview

Key Highlights:
As of Mar 03, 2025 OSCR Relative Value is $23.6, which is undervalued by 56.6%, compared to current share price of $15.1.
As of Mar 03, 2025 OSCR DCF Value is N/A, which is undervalued by N/A, compared to current share price of $15.1.
Methodology
Price per share, $
Current share price
15.1
DCF value
not available

OSCR Historical Intrinsic Value

Crunching data... Almost there!
Crunching data... Almost there!

OSCR Valuation Metrics

LTM
NTM
1Y Forward
2Y Forward
EV/Revenue
0.2x (as of Mar 03, 2025)
EV/Gross Profit
0.2x (as of Mar 03, 2025)
EV/EBIT
32.3x (as of Mar 03, 2025)
EV/EBITDA
20.8x (as of Mar 03, 2025)
EV/FCF
1.9x (as of Mar 03, 2025)
EV/OCF
1.9x (as of Mar 03, 2025)
P/Revenue
0.4x (as of Mar 03, 2025)
P/Gross Profit
0.4x (as of Mar 03, 2025)
P/EBIT
64.7x (as of Mar 03, 2025)
P/EBITDA
41.7x (as of Mar 03, 2025)
P/FCF
3.9x (as of Mar 03, 2025)
P/OCF
3.8x (as of Mar 03, 2025)
P/E
145.6x (as of Mar 03, 2025)
P/BV
3.6x (as of Mar 03, 2025)
PEG 1Y
0.2x (as of Mar 03, 2025)

OSCR DCF Model

Free Cash Flow to Firm Model
NOPAT Model
Free Cash Flow to Equity Model
Net Income Model
Millions
Billions
Dec'20 ActualDec'21 ActualDec'22 ActualDec'23 ActualDec'24 ActualDec'25 EstimateDec'26 EstimateDec'27 EstimateDec'28 EstimateDec'29 EstimateDec'30 EstimateDec'31 EstimateDec'32 EstimateDec'33 EstimateDec'34 EstimateDec'35 Terminal
% growth
589.6
6.5%
1,921.0
225.8%
4,125.6
114.8%
5,862.9
42.1%
9,177.6
56.5%
11,518.8
25.5%
11,667.9
1.3%
13,929.8
19.4%
16,344.9
17.3%
18,843.9
15.3%
21,339.1
13.2%
23,727.6
11.2%
25,897.4
9.1%
27,735.2
7.1%
29,135.3
5.0%
30,009.4
3.0%
(406.9)
(69.0%)
(577.1)
(30.0%)
(584.2)
(14.2%)
(235.6)
(4.0%)
57.3
0.6%
(3,752.8)
(32.6%)
(3,801.4)
(32.6%)
(4,538.3)
(32.6%)
(5,325.1)
(32.6%)
(6,139.3)
(32.6%)
(6,952.2)
(32.6%)
(7,730.3)
(32.6%)
(8,437.3)
(32.6%)
(9,036.0)
(32.6%)
(9,492.2)
(32.6%)
(9,776.9)
(32.6%)
NOPAT
% effective tax rate
(407.9)
(69.2%)
(577.9)
(30.1%)
(583.7)
(14.1%)
(238.5)
(4.1%)
44.8
0.5%
(2,932.6)
(25.5%)
(2,970.6)
(25.5%)
(3,546.5)
(25.5%)
(4,161.3)
(25.5%)
(4,797.6)
(25.5%)
(5,432.8)
(25.5%)
(6,040.9)
(25.5%)
(6,593.4)
(25.5%)
(7,061.3)
(25.5%)
(7,417.7)
(25.5%)
(7,640.3)
(25.5%)
% of revenue
11.3
1.9%
14.6
0.8%
15.3
0.4%
30.7
0.5%
32.1
0.4%
47.8
0.4%
48.4
0.4%
57.8
0.4%
67.8
0.4%
78.2
0.4%
88.5
0.4%
98.4
0.4%
107.4
0.4%
115.0
0.4%
120.8
0.4%
124.5
0.4%
% of revenue
(14.0)
(2.4%)
(25.9)
(1.3%)
(29.0)
(0.7%)
(25.6)
(0.4%)
(27.9)
(0.3%)
(55.4)
(0.5%)
(56.1)
(0.5%)
(67.0)
(0.5%)
(78.6)
(0.5%)
(90.7)
(0.5%)
(102.7)
(0.5%)
(114.2)
(0.5%)
(124.6)
(0.5%)
(133.4)
(0.5%)
(140.2)
(0.5%)
(144.4)
(0.5%)
575.7
97.6%
247.7
12.9%
858.0
20.8%
(192.1)
(3.3%)
838.9
9.1%
1,023.7
8.9%
1,036.9
8.9%
1,237.9
8.9%
1,452.6
8.9%
1,674.6
8.9%
1,896.4
8.9%
2,108.7
8.9%
2,301.5
8.9%
2,464.8
8.9%
2,589.2
8.9%
2,666.9
8.9%
Free Cash Flow to Firm (FCFF)
% of revenue
165.1
28.0%
(341.5)
(17.8%)
260.6
6.3%
(425.5)
(7.3%)
887.9
9.7%
(1,916.6)
(16.6%)
(1,941.4)
(16.6%)
(2,317.8)
(16.6%)
(2,719.6)
(16.6%)
(3,135.5)
(16.6%)
(3,550.6)
(16.6%)
(3,948.0)
(16.6%)
(4,309.1)
(16.6%)
(4,614.9)
(16.6%)
(4,847.8)
(16.6%)
(4,993.3)
(16.6%)
% of FCFF used in calculation
83.0%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
Discount period
0.50
1.50
2.50
3.50
4.50
5.50
6.50
7.50
8.50
9.50
Discount factor
0.95
0.86
0.78
0.71
0.64
0.58
0.53
0.48
0.43
0.39
Discounted FCFF (DFCFF)

OSCR DCF Value

DCF Value Calculation

as of Mar 03, 2025
Sum of DFCFF
% share of EV
N/A
30.0%
Terminal Value (TV)
N/A
Discounted TV
% share of EV
N/A
70.0%
Total Debt
299.6M
Shares outstanding
245.4M
FX rate
N/A
100% overvalued

Equity Value Bridge

OSCR Earnings Power Value and Enterprise Value

Annual
LTM
Enterprise Value Breakdown
EPV and MIVoG as % of EV

OSCR Reverse DCF

Implied FCF growth
Implied Revenue growth

Reverse DCF Assumptions and Outputs

as of Dec 31, 2024
Long-Term growth rate
3.0%
FX rate
1.0
Last share price
13.4
Implied FCF growth 1-10Y
(23.9%)

Implied Free Cash Flow growth vs Historical average vs Industry growth

Competing with OSCR Intrinsic Value

Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name
Market Cap
Enterprise Value
Intrinsic Value
DCF Value
Relative value
Ben Graham Revised fair value
Peter Lynch fair value
Earnings Power Value (EPV), % of EV
Market-Implied Value of Growth (MIVoG), % of EV
Reverse DCF (implied FCF growth)
Reverse DCF (implied Revenue growth)
$3,703.3M
$1,851.2M
$23.7
57.0% undervalued
N/A
$23.7
57.0% undervalued
$86.2
470.9% undervalued
$22.9
52.0% undervalued
22.2%
77.8%
(23.9%)
(18.2%)
$436.0B
$411.4B
$1,047.3
124.2% undervalued
$1,845.4
295.0% undervalued
$249.3
46.6% overvalued
$1,327.6
184.2% undervalued
$750.2
60.6% undervalued
79.8%
20.2%
0.4%
5.8%
$90.7B
$84.4B
$1,001.8
153.3% undervalued
$1,618.1
309.0% undervalued
$385.6
2.5% overvalued
$915.3
131.4% undervalued
$693.4
75.3% undervalued
635.5%
(535.5%)
(2.7%)
7.0%
$87.2B
$110.9B
$942.9
202.7% undervalued
$1,567.7
403.0% undervalued
$318.1
2.1% undervalued
$727.4
133.5% undervalued
$437.8
40.5% undervalued
78.7%
21.3%
(15.6%)
(13.8%)
$82.3B
$154.3B
$208.2
220.8% undervalued
$356.4
449.0% undervalued
$59.9
7.7% overvalued
$216.9
234.2% undervalued
$150.2
131.4% undervalued
142.1%
(42.1%)
(27.9%)
(24.5%)
$31.5B
$22.8B
$797.8
205.0% undervalued
$1,197.5
358.0% undervalued
$398.1
52.2% undervalued
$644.7
146.5% undervalued
$202.5
22.6% overvalued
209.5%
(109.5%)
(10.3%)
(100.0%)
$29.1B
$30.9B
$1,406.9
2,301.3% undervalued
$2,722.5
4,547.0% undervalued
$91.4
56.0% undervalued
$113.7
94.1% undervalued
$81.7
39.4% undervalued
148.1%
(48.1%)
(100.0%)
2.1%
$17.3B
$15.8B
$414.9
37.0% undervalued
$548.7
81.0% undervalued
$281.2
7.1% overvalued
$588.6
94.3% undervalued
$407.4
34.5% undervalued
185.0%
(85.0%)
4.3%
12.7%
$3,104.9M
$2,679.9M
$8.2
47.0% overvalued
N/A
$8.2
47.0% overvalued
$3.7
76.3% overvalued
$11.3
26.9% overvalued
(49.0%)
149.0%
(100.0%)
(100.0%)
$1,871.6M
$1,650.0M
$2.0
45.3% overvalued
N/A
$2.0
45.3% overvalued
$5.0
36.6% undervalued
$3.7
1.0% undervalued
(0.8%)
100.8%
2.3%
(100.0%)
$65.5M
$342.3M
$46.2
463.3% undervalued
N/A
$46.2
463.3% undervalued
$10.2K
123,982.2% undervalued
N/A
(5,799.3%)
5,899.3%
(100.0%)
(100.0%)

Intrinsic Valuation Tools

Wondering how to calculate intrinsic value of a stock? Use our intrinsic value tools to simplify complex valuation concepts and save time.

FAQ

What is the DCF value of Oscar Health, Inc. (OSCR)?

As of today, DCF Value of Oscar Health, Inc. is $0.0, which is undervalued by 0.0%, compared to the current market share price of $15.1

How was the DCF Value calculated?

Step 1: Calculating Intrinsic Enterprise Value DCF Value was calculated by estimating Oscar Health, Inc. future free cash flow and then discounting it, using a chosen discount rate to determine Intrinsic Enterprise Value of $0.0B Step 2: Balance Sheet Adjustments Intrinsic Equity Value is calculated by subtracting Balance Sheet items (Cash & Equivalents, Short-term investments and Total Debt) from previously calculated Intrinsic Enterprise Value. This Intrinsic Equity Value is then divided by the total number of outstanding shares of 0 to determine DCF Value of $0.0

What is the Relative value of Oscar Health, Inc. (OSCR)?

As of today, Relative Value of Oscar Health, Inc. is $23.7, which is undervalued by 57.0%, compared to the current market share price of $15.1

How was the Relative Value calculated?

Relative Value was calculated by applying various valuation multiples (EV/Revenue, EV/EBITDA, P/E etc.) to Oscar Health, Inc. financials to determine Relative Value of $23.7

What is Oscar Health, Inc. (OSCR) discount rate?

Oscar Health, Inc. current Cost of Equity is 11.1%, while its WACC stands at 10.4%. Cost of Equity is used to value equity, while discounting free cash flow to equity holders (such as Net Income or Free Cash Flow to Equity). Weighted Average Cost of Capital (WACC) is used to value the entire firm, while discounting cash flows available to both debt and equity holders (NOPAT or Free Cash Flow to the Firm)

How is Cost of Equity for Oscar Health, Inc. (OSCR) calculated?

The Cost of Equity represents the return a company must offer investors to compensate for the risk of investing in its stock. It's calculated using the Capital Asset Pricing Model (CAPM), which combines the risk-free rate, the stock's beta, and the equity risk premium (ERP). This model considers the inherent risk of investing in the stock compared to a risk-free investment and the market's overall risk. Cost of Equity = Risk-Free Rate + Beta x Effective Risk Premium (ERP) 11.1% = 4.2% + 1.5 x 4.6%

How is WACC for Oscar Health, Inc. (OSCR) calculated?

WACC, or Weighted Average Cost of Capital, is a calculation that reflects the average rate of return a company is expected to pay its security holders to finance its assets. It is a critical measure in financial analysis for valuing a company's entire operations. The WACC formula combines the costs of equity and debt, weighted by their respective proportions in the company's capital structure. WACC = Cost of Equity x Equity Weight in Total Capital + Cost of Debt x (1 - Effective Tax Rate) Debt Weight in Total Capital 10.4% = 11.1% x 7.5% + 2.0% x (1 - 0.3%) x 92.5%